Dr. Anthony Fauci, the White House’s top epidemiologist has been accused of running a “misinformation campaign” against the controversial anti-malarial-turned-COVID-19 treatment, hydroxychloroquine.
Dr. Harvey Risch, a Yale epidemiologist, has said in the past that hydroxychloroquine is “the key to defeating COVID-19,” despite the media campaign against the drug. Fauci, on the other hand, has consistently downplayed the drug’s potential as a treatment for the novel coronavirus.
Fauci said during a Thursday interview that “the overwhelming prevailing clinical trials that have looked at the efficacy of hydroxychloroquine have indicated that it is not effective in [treating] coronavirus disease.” Risch disagrees with Fauci’s assessment, and told Just The News on Thursday that Fauci “has been maintaining a studious position that only randomized controlled trial evidence has any value and everything else he calls anecdotal.”
No randomized controlled trials — considered the “gold standard” of clinical research — have been performed in regard to using hydroxychloroquine for the specific treatment of COVID-19, though the drug has been used for decades as an anti-malarial, as well as for a variety of other diseases and disorders with a proven safety and effectiveness track record.
Risch has cited a dozen studies from around the world that prove that hydroxychloroquine is an effective treatment against COVID-19 when used at the right time and on the right patient.
Risch argued that the drug “shows benefits” in a set of strict conditions — “(a) early treatment of (b) high-risk (c) outpatients with (d) HCQ plus zinc, [azithromycin], doxycycline etc. for (e) hospitalization or mortality outcomes,” and explained that when used within these parameters, the drug is highly effective.
He blasted Fauci for ignoring the nuance of the current studies on the efficacy of hydroxychloroquine, saying that Fauci “smeared all over” those five conditions.
Risch pointed out that opponents of using the drug on COVID-19 patients have used evidence that it doesn’t work on “patients near death in ventilators” as evidence that it won’t work on “healthier patients in outpatient settings.”
“Why would you even entertain invoking a study on severely sick patients to bear on the efficacy of outpatients?” He concluded.